Phocas Financial Corp. Abb Vie Inc. Transaction History

Phocas Financial Corp.

$134 Billion
Q4 2024

A detailed history of Phocas Financial Corp. transactions in Abb Vie Inc. stock. As of the latest transaction made, Phocas Financial Corp. holds 26,200 shares of ABBV stock, worth $5.14 Million. This represents 3.46% of its overall portfolio holdings.

Number of Shares

26,200

Previous 26,350 0.57%

Holding current value

$5.14 Million

Previous $5.2 Billion 10.53%

% of portfolio

3.46%

Previous 19.89%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$164.99 - $203.87 $24,748 - $30,580	-150 Reduced 0.57%	26,200 $4.66 Billion
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $4.21 Million - $4.8 Million	-26,350 Reduced 50.0%	26,350 $4.8 Billion
Q1 2024 Apr 17, 2024	BUY	$159.82 - $182.1 $4.21 Million - $4.8 Million	26,350 Added 100.0%	52,700 $4.8 Billion
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $850,918 - $958,334	-6,184 Reduced 19.01%	26,350 $4.08 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $30,725 - $35,569	-230 Reduced 0.7%	32,534 $4.85 Million
Q1 2023 Apr 13, 2023	SELL	$144.61 - $166.54 $373,093 - $429,673	-2,580 Reduced 7.3%	32,764 $5.22 Million
Q4 2022 Jan 10, 2023	SELL	$138.31 - $165.87 $104,562 - $125,397	-756 Reduced 2.09%	35,344 $0
Q3 2022 Oct 14, 2022	BUY	$134.21 - $153.93 $139,578 - $160,087	1,040 Added 2.97%	36,100 $4.85 Million
Q1 2022 May 25, 2022	SELL	$131.98 - $163.75 $50,284 - $62,388	-381 Reduced 1.08%	35,060 $5.68 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $40,085 - $44,657	381 Added 1.09%	35,441 $3.99 Million
Q1 2021 Jun 22, 2021	SELL	$102.3 - $112.62 $28,746 - $31,646	-281 Reduced 0.8%	35,060 $3.79 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $10,309 - $12,099	120 Added 0.34%	35,341 $3.1 Million
Q2 2020 Aug 24, 2020	SELL	$73.37 - $98.18 $43,214 - $57,828	-589 Reduced 1.64%	35,221 $3.46 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $14,835 - $22,491	230 Added 0.65%	35,810 $2.73 Million
Q3 2019 Nov 15, 2019	BUY	$62.98 - $75.72 $2.24 Million - $2.69 Million	35,580 New	35,580 $2.69 Million
Q2 2019 Aug 16, 2019	SELL	$65.7 - $83.98 $2.34 Million - $2.99 Million	-35,580 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $8,485 - $9,986	-110 Reduced 0.31%	35,580 $2.87 Million
Q4 2018 Feb 15, 2019	SELL	$77.85 - $96.01 $30,361 - $37,443	-390 Reduced 1.08%	35,690 $3.29 Million
Q3 2018 Nov 15, 2018	SELL	$88.91 - $98.84 $20,716 - $23,029	-233 Reduced 0.64%	36,080 $3.41 Million
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $3.25 Million - $3.57 Million	36,313	36,313 $0

Others Institutions Holding ABBV

# of Institutions

4,082

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $347B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

News

Stay updated on Phocas Financial Corp. with notifications on news.

Account

Phocas Financial Corp. Abb Vie Inc. Transaction History